UX-GIP001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UX-GIP001, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) [EARLY_Phase 1]